The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients

Eva Pericolini, Alessia Alunno, Elena Gabrielli, Elena Bartoloni, Elio Cenci, Siu Kei Chow, Giovanni Bistoni, Arturo Casadevall, Roberto Gerli, Anna Vecchiarelli

Research output: Contribution to journalArticle

Abstract

The persistence of activated T cells in rheumatoid arthritis (RA) synovium may be attributable to increased homing, increased retention or a possible imbalance between cell proliferation and programmed cell death. Induction of apoptosis may represent a potential therapeutic approach. Galactoxylomannan (GalXM) from the opportunistic fungus Cryptococcus neoformans can interact with T cells and induce T-cell apoptosis through the inhibition of CD45 phosphatase activity. The aim of this study was to determine the effect of GalXM on circulating T cells from patients with RA and the underlying mechanisms. GalXM immunomodulating effect on apoptosis and signal transduction pathway involved in IL-17A production was evaluated on T cells. RA T-cell apoptosis, higher than that of control T cells, was further increased by GalXM through induction of caspase-3 activation. Activated T cells expressing the CD45RO molecule and producing IL-17A were the main target of GalXM-induced apoptosis. GalXM induced consistent impairment of IL-17A production and inhibition of STAT3, which was hyperactivated in RA. In conclusion, GalXM triggered apoptosis of activated memory T cells and interfered with IL-17A production in RA. These data suggest therapeutic targeting of deleterious Th17 cells in RA and other autoimmune diseases.

Original languageEnglish (US)
Article numbere53336
JournalPLoS One
Volume8
Issue number1
DOIs
StatePublished - Jan 8 2013
Externally publishedYes

Fingerprint

rheumatoid arthritis
T-cells
Interleukin-17
Polysaccharides
Rheumatoid Arthritis
polysaccharides
T-lymphocytes
T-Lymphocytes
apoptosis
Apoptosis
galactoxylomannan
Th17 Cells
Signal transduction
therapeutics
Cryptococcus neoformans
Synovial Membrane
autoimmune diseases
Cell proliferation
Cell death
caspase-3

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Pericolini, E., Alunno, A., Gabrielli, E., Bartoloni, E., Cenci, E., Chow, S. K., ... Vecchiarelli, A. (2013). The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients. PLoS One, 8(1), [e53336]. https://doi.org/10.1371/journal.pone.0053336

The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients. / Pericolini, Eva; Alunno, Alessia; Gabrielli, Elena; Bartoloni, Elena; Cenci, Elio; Chow, Siu Kei; Bistoni, Giovanni; Casadevall, Arturo; Gerli, Roberto; Vecchiarelli, Anna.

In: PLoS One, Vol. 8, No. 1, e53336, 08.01.2013.

Research output: Contribution to journalArticle

Pericolini, E, Alunno, A, Gabrielli, E, Bartoloni, E, Cenci, E, Chow, SK, Bistoni, G, Casadevall, A, Gerli, R & Vecchiarelli, A 2013, 'The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients', PLoS One, vol. 8, no. 1, e53336. https://doi.org/10.1371/journal.pone.0053336
Pericolini, Eva ; Alunno, Alessia ; Gabrielli, Elena ; Bartoloni, Elena ; Cenci, Elio ; Chow, Siu Kei ; Bistoni, Giovanni ; Casadevall, Arturo ; Gerli, Roberto ; Vecchiarelli, Anna. / The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients. In: PLoS One. 2013 ; Vol. 8, No. 1.
@article{8051293efd564beca652d1fe694b7109,
title = "The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients",
abstract = "The persistence of activated T cells in rheumatoid arthritis (RA) synovium may be attributable to increased homing, increased retention or a possible imbalance between cell proliferation and programmed cell death. Induction of apoptosis may represent a potential therapeutic approach. Galactoxylomannan (GalXM) from the opportunistic fungus Cryptococcus neoformans can interact with T cells and induce T-cell apoptosis through the inhibition of CD45 phosphatase activity. The aim of this study was to determine the effect of GalXM on circulating T cells from patients with RA and the underlying mechanisms. GalXM immunomodulating effect on apoptosis and signal transduction pathway involved in IL-17A production was evaluated on T cells. RA T-cell apoptosis, higher than that of control T cells, was further increased by GalXM through induction of caspase-3 activation. Activated T cells expressing the CD45RO molecule and producing IL-17A were the main target of GalXM-induced apoptosis. GalXM induced consistent impairment of IL-17A production and inhibition of STAT3, which was hyperactivated in RA. In conclusion, GalXM triggered apoptosis of activated memory T cells and interfered with IL-17A production in RA. These data suggest therapeutic targeting of deleterious Th17 cells in RA and other autoimmune diseases.",
author = "Eva Pericolini and Alessia Alunno and Elena Gabrielli and Elena Bartoloni and Elio Cenci and Chow, {Siu Kei} and Giovanni Bistoni and Arturo Casadevall and Roberto Gerli and Anna Vecchiarelli",
year = "2013",
month = "1",
day = "8",
doi = "10.1371/journal.pone.0053336",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients

AU - Pericolini, Eva

AU - Alunno, Alessia

AU - Gabrielli, Elena

AU - Bartoloni, Elena

AU - Cenci, Elio

AU - Chow, Siu Kei

AU - Bistoni, Giovanni

AU - Casadevall, Arturo

AU - Gerli, Roberto

AU - Vecchiarelli, Anna

PY - 2013/1/8

Y1 - 2013/1/8

N2 - The persistence of activated T cells in rheumatoid arthritis (RA) synovium may be attributable to increased homing, increased retention or a possible imbalance between cell proliferation and programmed cell death. Induction of apoptosis may represent a potential therapeutic approach. Galactoxylomannan (GalXM) from the opportunistic fungus Cryptococcus neoformans can interact with T cells and induce T-cell apoptosis through the inhibition of CD45 phosphatase activity. The aim of this study was to determine the effect of GalXM on circulating T cells from patients with RA and the underlying mechanisms. GalXM immunomodulating effect on apoptosis and signal transduction pathway involved in IL-17A production was evaluated on T cells. RA T-cell apoptosis, higher than that of control T cells, was further increased by GalXM through induction of caspase-3 activation. Activated T cells expressing the CD45RO molecule and producing IL-17A were the main target of GalXM-induced apoptosis. GalXM induced consistent impairment of IL-17A production and inhibition of STAT3, which was hyperactivated in RA. In conclusion, GalXM triggered apoptosis of activated memory T cells and interfered with IL-17A production in RA. These data suggest therapeutic targeting of deleterious Th17 cells in RA and other autoimmune diseases.

AB - The persistence of activated T cells in rheumatoid arthritis (RA) synovium may be attributable to increased homing, increased retention or a possible imbalance between cell proliferation and programmed cell death. Induction of apoptosis may represent a potential therapeutic approach. Galactoxylomannan (GalXM) from the opportunistic fungus Cryptococcus neoformans can interact with T cells and induce T-cell apoptosis through the inhibition of CD45 phosphatase activity. The aim of this study was to determine the effect of GalXM on circulating T cells from patients with RA and the underlying mechanisms. GalXM immunomodulating effect on apoptosis and signal transduction pathway involved in IL-17A production was evaluated on T cells. RA T-cell apoptosis, higher than that of control T cells, was further increased by GalXM through induction of caspase-3 activation. Activated T cells expressing the CD45RO molecule and producing IL-17A were the main target of GalXM-induced apoptosis. GalXM induced consistent impairment of IL-17A production and inhibition of STAT3, which was hyperactivated in RA. In conclusion, GalXM triggered apoptosis of activated memory T cells and interfered with IL-17A production in RA. These data suggest therapeutic targeting of deleterious Th17 cells in RA and other autoimmune diseases.

UR - http://www.scopus.com/inward/record.url?scp=84872195081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872195081&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0053336

DO - 10.1371/journal.pone.0053336

M3 - Article

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e53336

ER -